All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2007-001014-17 | A Phase II, multicentre, double-blind, randomized, dose range finding placebo controlled study of Rifaximin- EIR tablet: clinical effectiveness and tolerability in the treatment of moderate, active Cr... | 2009-09-23 | due-trials |
| Reported results | 2009-011826-32 | A phase II, multicentre, double-blind, randomised, placebo-controlled study on efficacy and tolerability of Rifaximin vaginal tablets in the treatment of bacterial vaginosis | 2010-10-18 | due-trials |
| Reported results | 2009-016923-77 | Multicentre, randomised, double blind, placebo controlled study on long-term treatment with Sulodexide for prevention of recurrent DVT in patients with venous thromboembolism | 2014-10-28 | due-trials |
| Completed, but no date, and reported results Terminated | 2010-024177-39 | Prospective microbiological study on patients with non-constipation IBS treated with rifaximin 550 mg tablets. | bad-data | |
| Completed, but no date Terminated | 2011-002821-24 | Prospective pharmacodynamic study on patients with moderate, active Crohn’s disease treated with Rifaximin-EIR 400 mg tablets. Studio prospettico di farmacodinamica in pazienti con morbo di Crohn d... | bad-data | |
| Reported results | 2015-002969-27 | A RANDOMISED, SINGLE-BLIND, ACTIVE CONTROLLED, MULTI-CENTRE TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, ACCEPTABILITY AND PALATABILITY OF PMF104 COMPARED TO A CONVENTIONAL PEG-ELECTROLYTE SO... | 2021-03-05 | due-trials |
| Ongoing | 2016-000783-42 | A phase 3, prospective, open, pilot, monocentric study to evaluate the effect of sulodexide administered at registered dose on morphology and functional properties of the venous endothelium in patient... | not-yet-due |